Environmental Risk Assessment (ERA) for PMTA Compliance

Ecotoxicological Evaluation for E-Liquids, ENDS Devices & Nicotine Products. Environmental impact matters—not just ethically, but legally. Under the PMTA framework, the FDA requires applicants to assess the potential environmental consequences of marketing a new tobacco product in the U.S. That's where the Environmental Risk Assessment (ERA) comes in.

At Gegahelix, we help you fulfill this often-overlooked but essential requirement. Our ERA reports are tailored for e-liquids, ENDS devices, nicotine pouches, and oral products, and are fully aligned with 21 CFR Part 25 and FDA's Environmental Assessment guidance for tobacco products.

What Is an Environmental Risk Assessment?

An Environmental Risk Assessment (ERA) evaluates the potential environmental effects associated with below area of your product. This includes all components: e-liquid residues, device materials, aerosol emissions, packaging waste, and batteries.

The ERA is included in Module 8 of the PMTA and may determine whether your product is eligible for a Categorical Exclusion (CE) or must undergo a full Environmental Assessment (EA).

  • Manufacture
  • Use
  • Disposal

Gegahelix ERA Services Include

Product-Specific Environmental Profiles:

  • E-liquids (nicotine, propylene glycol, glycerin, flavorants)
  • ENDS hardware (coils, tanks, plastic components, lithium-ion batteries)
  • Nicotine pouches & oral products (plant fibers, wrappers, sweeteners)
  • Secondary packaging (boxes, blisters, films, inserts)

Key Areas of Assessment:

  • Chemical persistence and environmental fate (air, water, soil)
  • Bioaccumulation potential of ingredients
  • Ecotoxicity of leachables (aquatic and terrestrial organisms)
  • Disposal impact (landfill burden, e-waste)
  • Production footprint (energy, solvents, emissions if disclosed)

Categorical Exclusion vs. Full EA

Gegahelix evaluates your eligibility for FDA Categorical Exclusion under 21 CFR §25.32(i) or prepares a full Environmental Assessment if needed.

Categorical Exclusion (CE)

We provide documentation and justification to support CE eligibility, typically for:

  • Products that do not increase environmental exposure to toxic substances
  • Reformulated or line-extension products with minimal risk

Full Environmental Assessment (EA)

When required, our comprehensive EA report includes:

  • Description of product and its use
  • Analysis of environmental releases (intentional and incidental)
  • Impact on natural resources and waste systems
  • Alternatives analysis, mitigation strategies, and cumulative impact review

Scientific Rigor & Regulatory Alignment

Our ERA reports are backed by:

  • EPA databases, ECHA/REACH dossiers, HSDB, and environmental exposure models
  • Literature-based and model-based ecotoxicology estimates
  • Integration with toxicology data from your PMTA
  • Fully formatted for FDA's Environmental Assessment template

Add-On Services

  • Toxicological Summary Integration for ecological endpoints
  • Battery & e-waste risk modeling for hardware-heavy devices
  • Custom leachables/extractables evaluations
  • Sustainability consulting for packaging and supply chain optimization

Who This Is For

  • ENDS brands filing full PMTA submissions
  • OEM/white-label vape manufacturers
  • Regulatory consultants managing PMTA pipelines
  • Ingredient suppliers supporting client submissions
  • Labs and CROs conducting aerosol and toxicology testing

Why Gegahelix for ERA?

  • ✅ Built for PMTA Compliance: We focus specifically on FDA's tobacco regulatory expectations—not generic sustainability reports.
  • ✅ Expert Justifications for CE or EA: Our reports anticipate reviewer questions and avoid costly delays.
  • ✅ Environmental Responsibility, Backed by Science: We help you position your product as both compliant and conscious.

Talk to a PMTA Expert

Our dedicated FDA regulatory experts partner closely with your team, guiding you step-by-step through the PMTA submission process. Receive tailored support in toxicological assessments, ingredient evaluations, and compliance strategies, ensuring your ENDS, e-liquid, nicotine pouch, or nicotine patch products confidently navigate FDA approval.

Navigate FDA submissions with clarity—partner with Gegahelix to streamline your path to regulatory compliance and sustained market success.

Connect Here